Warm Autoimmune Hemolytic Anemia
📧 Sign up to get email alerts when something new happens for Warm Autoimmune Hemolytic Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) [Phase 2]
Phase 2 trial assessing safety, tolerability, pharmacokinetics and pharmacodynamics of ANX005 in warm autoimmune hemolytic anemia (wAIHA) co…
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia [Phase 3]
Phase 3 trial update for ianalumab in previously treated warm autoimmune hemolytic anemia (wAIHA) assessing efficacy and safety; status ACTI…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia [Phase 2, Phase 3]
This clinical trial update reports on the efficacy and safety of M281 in adults with Warm Autoimmune Hemolytic Anemia, spanning Phase 2 and …
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease [Phase 1, Phase 2]
CRISPR Therapeutics reports safety data and preliminary efficacy signals for CTX112 in adults with relapsed/refractory warm autoimmune hemol…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia [Phase 2, Phase 3]
This clinical trial update reports on the efficacy and safety of M281 in adults with Warm autoimmune hemolytic anemia across Phase 2 and Pha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab [Phase 2]
Phase 2 clinical trial evaluating Ianalumab in adults with primary immune thrombocytopenia and warm autoimmune hemolytic anemia who previous…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia [Phase 3]
A Phase 3 trial evaluating the efficacy, safety, and pharmacokinetics of oral rilzabrutinib versus placebo in adults with warm autoimmune he…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia [Phase 3]
A Phase 3 clinical trial update evaluating the efficacy and safety of ianalumab in previously treated patients with warm autoimmune hemolyti…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia [Phase 2, Phase 3]
HMPL-523 (Sovleplenib) is being studied for warm autoimmune hemolytic anemia in Phase 2 and Phase 3, and the trial is currently active but n…
-
CLINICAL_TRIALS other · 2026-01-16Clinical Trial Update: Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
This document provides an update on post-trial access for Nipocalimab in participants with warm autoimmune hemolytic anemia.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Sirolimus in the Treatment of Refractory/Relapsed wAIHA [NA]
Sirolimus is being studied for refractory/relapsed warm autoimmune hemolytic anemia, and the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias [Phase 1, Phase 2]
Open-label Phase 1/2 study evaluating povetacicept in autoimmune cytopenias. The study includes immune thrombocytopenia and idiopathic throm…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) [Phase 3]
This document provides a Phase 3 trial update for obexelimab in warm autoimmune hemolytic anemia, noting that the study is currently active …
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA) [Phase 2]
A Phase 2 clinical trial evaluates the efficacy, safety, and pharmacokinetics of rilzabrutinib in patients with warm autoimmune hemolytic an…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia [Phase 3]
A Phase 3 trial evaluating Parsaclisib for warm autoimmune hemolytic anemia was terminated, and efficacy and safety results have been posted…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD) [Phase 2]
A Phase 2 trial evaluating APL-2 in warm autoimmune hemolytic anemia and cold agglutinin disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA) [Phase 2]
A Phase 2 trial evaluating subcutaneous isatuximab in adults with warm autoimmune hemolytic anemia (wAIHA) was terminated; results detailing…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA [Phase 2]
Phase 2 trial update evaluating zanubrutinib for relapsed/refractory warm autoimmune hemolytic anemia (wAIHA) with recruitment currently ong…
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) [Phase 2]
Phase 2 trial update on ANX005 assessing safety, tolerability, PK/PD in participants with warm autoimmune hemolytic anemia (wAIHA).
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA). [Phase 2]
Phase 2 trial assessing the efficacy and safety of RVT-1401 in warm autoimmune hemolytic anemia was terminated; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA) [Phase 1, Phase 2]
A safety study of SYNT001 in participants with Warm Autoimmune Hemolytic Anemia (WAIHA)—terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Rituximab in Auto-Immune Hemolytic Anemia [Phase 3]
A Phase 3 trial evaluating Rituximab for warm autoimmune hemolytic anemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining levamisole with prednisolone for warm autoimmune hemolytic anemia; current sta…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 single-arm pilot study evaluating low-dose rituximab plus standard prednisone for idiopathic autoimmune hemolytic anemia; the trial …